Advancing global pharma through integrated API manufacturing at scale.

Meet our team at

Stand No.- 2J22

06–08 October 2026

Fiera Milano, Italy

Book your meeting time

IOLCP Plant

About IOLCP

For more than three decades, we have developed and manufactured APIs for pharmaceutical companies worldwide. Our integrated manufacturing operations give us greater control over quality, cost, and supply across the value chain.

Our growing portfolio spans a wide range of therapeutic categories, including pain management, antidiabetic, cardiovascular, central nervous system, and anti-ulcer APIs. Strong R&D capabilities, robust quality systems and large-scale manufacturing enable us to meet the evolving needs of global pharma.

At IOLCP, we believe dependable supply begins with strong capabilities and is strengthened through lasting partnerships. That is why we remain focused on consistent quality, responsive support, and delivering on our commitments.

Learn More

About CPHI Milan

CPHI Milan brings together leading companies, innovators, and professionals from the global pharmaceutical supply chain. The event provides a valuable platform to explore emerging solutions, discover new capabilities, and connect with potential partners from across the industry.

Through face-to-face meetings, expert-led discussions, and collaborative opportunities, attendees can exchange ideas, gain valuable industry insights, and build relationships that support long-term business growth.

Beyond the event, CPHI’s year-round online platform helps pharma professionals stay connected with companies, products, and industry insights from around the globe.

CPHI Milan

Who we are

IOLCP combines manufacturing expertise, scientific capability, and a deep understanding of customer needs. Our teams across R&D, production, quality, and supply work together to deliver reliable API solutions for pharmaceutical companies worldwide.

Years Experience
35+ years
R&D Experts
120+ R&D experts
Workforce
3000+ workforce
Our Vision

Our Vision

To be amongst the most admired companies in APIs, Intermediaries, and Specialty Chemicals globally.

Our Mission

Our Mission

To provide top quality products in APIs, Intermediates and Specialty Chemicals through continuous innovation and cutting-edge technology, with due regards to safety and environment.

Our Values

Our Values

We at IOL, believe values bring character to any organization that help leaders to guide teams for a culture of excellence through continuous improvements.

Our Milestone

  • 1986
  • 1996
  • 1999
  • 2000
  • 2007
  • 2009
  • 2010
  • 2012
  • 2013
  • 2015
  • 2016
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021
1986 Milestone

1986

IOL Chemicals and Pharmaceutical Limited was incorporated in 1986 with Acetic Acid Plant.

1996 Milestone

1996

Commencement of Ethyl Acetate Plant

1999 Milestone

1999

Commencement of Acetic Anhydride Plant

2000 Milestone

2000

Commencement of Ibuprofen Unit-1

2007 Milestone

2007

Established Unit-1 dedicated for Ibuprofen Established Multi fuel captive co-generation power plant of 4MW capacity

2009 Milestone

2009

Commencement of Iso Butyl Benezene, Mono Chloro Acetic Acid and Acetyl Chloride Plant leading to backward integration to Ibuprofen

2010 Milestone

2010

IOL gets listed on the National Stock Exchange (NSE) Established Multi fuel captive co-generation power plant of 13MW capacity 2012

2012 Milestone

2012

Commencement of Unit-2 for Multi product

2013 Milestone

2013

Received EUGMP certification

2015 Milestone

2015

USFDA EIR for Ibuprofen

2016 Milestone

2016

Commencement of Unit-3 for new product launches

2017 Milestone

2017

Conversion of Unit-2 as dedicated facility for Ibuprofen

2018 Milestone

2018

Established Unit-4 dedicated for Metformin Hydrochloride Unit-5 dedicated for Clopidogrel Bisulfate Form II & Fenofibrate

2019 Milestone

2019

Established Unit-6 dedicated for Pantoprazole Sodium

2020 Milestone

2020

Established Unit-7 dedicated for Metformin

2021 Milestone

2021

Established Unit-8 for Multi Products

Market Presence

Global Market Presence Map